Thorir Bjornsson - VP Early Devlopment

Description: activators, and amyloid β-peptide. Clinical research interests have included early clinical development and clinical pharmacology studies, ranging from First-in-Human studies and Proof-of-Concept studies, through Phase IIIb and Phase IV pharmacology studies. Other active interest areas include predictive models of efficacy, safety and compound properties; biomarkers and bioimaging; biosimulations; unmet medical need assessment; and strategic aspects of drug development. He is the author or co ...